Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,687 total articles
Hims & Hers (HIMS) is a growthy telehealth play that has momentum, but a heavy legal/regulatory overhang, thin free cash flow relative to market cap, and a business model tied to third-party advertising make it a weaker beneficiary of healthcare AI than scale-driven pharmacy services. I recommend a tactical short: entry $28.76, target $16.00, stop …
Cirrus Logic moved to M&A to accelerate development in higher-performance mixed-signal and AI-ready audio camera domains. Strong FCF, no net debt and a sub-13x earnings multiple make a tactical long attractive around $107 with a clear stop and target. This trade banks on successful integration and renewed design wins from Apple's device roadmap as …
Murphy Oil is progressing multiple growth projects while trimming operating costs. Recent production beats, a $125M FPSO purchase with a two-year payback, and $306M in free cash flow support a constructive trade. Valuation metrics (EV/EBITDA ~3.9, P/E ~19, price-to-book ~1.06) leave room for re-rating if commodity tailwinds persist. We outline an a…
Nvidia's dominance in AI GPUs and software is increasingly reflected in durable cash flows, but the stock's forward pricing no longer reflects that reality. This trade targets a meaningful re-rating over the next several months while keeping a disciplined stop if momentum breaks.
Ciena is squarely in the sweet spot of AI-driven networking demand. Recent wins and analyst upgrades point to outsized revenue and earnings revisions, yet the stock still trades at premium multiples. We outline a tactical long trade that aims to capture continued demand re-rating while containing downside with a clear stop.
The Walt Disney Company is a plays-on-execution trade: expanding cruise capacity, a loaded live-events calendar, and evidence of improved streaming retention create a clear earnings runway into fiscal 2027. Valuation is reasonable at ~21-22x trailing earnings and the company generates meaningful free cash flow, making a measured long position attra…
Sterling Infrastructure (STRL) has pulled back roughly half from its 52-week high but continues to show improving margins, strong free cash flow and healthy returns on equity. This trade idea takes a long stance with a clear entry, stop and target over a multi-month horizon while calling out execution and macro risks.
IonQ plunged on acquisition anxiety and short-term selling but fundamentals and sector catalysts give a plausible path to $60. This trade idea lays out a high-risk long: entry $31.70, stop $25.00, target $60.00, with a long-term horizon (180 trading days). Expect volatility; manage size accordingly.
Marvell is the pure-play connectivity and custom silicon beneficiary of the AI datacenter build-out. At $268.84 the stock already prices strong growth, yet Marvell's market-leading networking products, expanding optical portfolio, and roadmap into custom accelerators support another leg of upside. This trade buys the continued adoption of 800G/1.6T…
Nu Holdings just crossed a $1B quarterly profit milestone and is increasingly driving revenue per active customer higher. With 139 million customers, improving ARPAC and solid free cash flow, the company is entering the monetization stage of its playbook. This trade idea lays out a long entry, time horizon, targets and stop, and the key risks that …
Enviri looks like a classic small-cap takeover candidate: limited public float, asset-level optionality and an industry backdrop that encourages consolidation. We recommend a tactical long with strict risk controls aimed at capturing a potential buyout premium by 2028 while managing the reality of liquidity and execution risk.
First Tracks Biotherapeutics (TRAX) is a clinical-stage immunology company trading at a $1.13B market cap. Market action suggests investors are pricing in Teva's validation of the underlying pathway, which in turn elevates ANB033 as a potential receptor-owning asset. This trade idea proposes a tactical long: entry $31.50, target $45.00, stop $27.00…
HPE's acquisition of Juniper and accelerating Cloud & AI demand are forcing short sellers to cover. With record quarterly revenue, manageable leverage and bullish technicals, HPE looks like a tactical long for investors willing to accept event risk. This trade plan sets a clear entry, stop and target with a 180-trading-day horizon.
Short-term chatter that AI spending will cool has pushed some traders to question Microsoft’s multiple. Fundamentals say otherwise: $MSFT trades at a P/E of ~30 with $66.99B in free cash flow, a fortress balance sheet and persistent Azure momentum. This trade idea lays out an entry at $544.26, a stop at $490.00 and a target of $650.00 over a long-t…
BrightSpring (BTSG) is showing tangible operational improvement: adjusted EBITDA grew ~44% year-over-year and margins expanded to 5.3% as the company deploys AI, automation and Lean across its pharmacy and provider operations. The stock trades near $62.67 with an EV/EBITDA of ~23 and free cash flow of about $402M; we see room for re-rating if execu…
Guggenheim Strategic Opportunities Fund (GOF) is sitting near its 52-week low at $8.89, trading with a price-to-book of 0.83 and a distribution yield near 24.5%. Technical momentum is constructive and liquidity is good. This trade idea outlines a mid-term income-driven long with clear entry, stop and target levels and a plan to manage the high risk…
<p>Amkor is in the middle of a capacity buildout for advanced packaging that is already showing up in revenue and margin improvement. The market is pricing the stock at roughly a mid-teens EV/EBITDA and a P/E near 21x despite consensus EPS growth of >70% for the year. That divergence creates a defined long trade: buy into improving fundamentals whi…
FIGS has more than doubled in the last 12 months, but improving unit economics, rising active customers and a clean balance sheet leave room for multiple expansion. This trade plan offers an entry at $18.00, a stop at $14.00 and a primary target of $31.00 on a long-term (180 trading days) horizon while tracking nearer-term setups for partial profit…
Nurix (NRIX) delivered a shockingly strong Q3 with $673.06M revenue and $4.73 EPS, and its June partnership with Roche for bexobrutideg combined with a deep targeted-protein-degradation pipeline underpins a long-term trade. Valuation is modest (PE ~8.2, market cap ~$2.3B) relative to growth runway and cash generation. We rate NRIX Strong Buy with a…
O-I Glass is trading like a distressed company while still generating industrial-scale cash flow and sitting on assets that could be worth far more than the current market cap. The recent goodwill charge, guidance cut and legal inquiries are real negatives, but the share price - near $5.90 - implies near-zero long-term value for a company that cont…
Woodside trades at a low-teens P/E, a sub-1.3 P/B and a ~4.9% yield while technicals show constructive momentum. With several development projects providing a potential cash-flow inflection and an LNG market that remains tight, the risk-reward favors a long position. Trade plan below with entry, stop and targets.
Marvell is squarely in the path of AI-driven infrastructure upgrades. With a $244B market cap, profitable operations, and free cash flow, the stock looks investable as a tactical long into continued customer ramps — provided execution matches lofty expectations and valuation does not reprice lower.
We upgrade Millrose Properties (MILL) to Buy. Short-term headlines around buy-to-rent competition and macro uncertainty have depressed the stock, but the company’s operating cash flow, occupancy resilience and conservative balance sheet give room to both ride out a softer near-term leasing environment and capture upside as fundamentals normalize. T…
Archer Aviation is an early-stage eVTOL developer whose stock is trading near 52-week lows. Boeing's planned acquisition of certain subsidiaries tied to Archer's business is the primary catalyst we’re betting on — it materially shortens the runway on manufacturing, certification know-how, and defense relationships. The trade below treats the Boeing…
Eni is trading near its 52-week highs on constructive fundamentals: a market cap of ~$86.5B, a 13.6x P/E, 1.57x PB and a near 3% dividend yield. Recent deals to monetize Indonesian upstream stakes, positive analyst revisions and bullish technical momentum create a favorable risk-reward for a mid-term long trade. Entry $57.65, target $64.00, stop $5…
